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Summary Six human T cell lines HAMA, KUN, KAN, TCL-Haz, TCL-Ter, and TCL-Mor, which were
transformed by a retrovirus, human T-cell leukaemia virus (HTLV), constitutively produced plasminogen
activators (PAs) in culture supernatants. The amount of PAs produced varied among the cell lines. The PAs
were distinguished by immunochemical analysis between two types: urokinase (UK)-type and non-UK-type.
KUN, TCL-Ter, and HAMA mainly produced UK-type PA, whereas the other cell lines produced both
types. Thus, HTLV-transformed T cell lines differ in the quality and quantity of the PAs they produce. The
PAs in the culture supernatants of each cell line were separated into several mol. w forms on sodium dodecyl
sulfate polyacrylamide gel electrophoresis. The results indicate that the same cell line produces PAs of
different mol. wt. PA production by these cell lines was affected by treatment with phorbol miristate acetate,
concanavalin A, and phytohaemagglutinin; the effects were substantially different in each cell line.
The data described here indicate that HTLV-transformed T cell lines constitutively produce PAs which are very
heterogeneous in both quality and quantity.
Plasminogen activators (PAs) convert plasminogen
to an active form, plasmin, which in turn degrades
fibrin and other protein substrates. PAs have been
found in various normal tissues, body fluids (Rijkin
et al., 1981), secretions (Sobel et al., 1952), and
cultured cells in vitro (Wilson et al., 1980; Rijken &
Collen, 1981). PAs exist in several molecular forms
that are distinguishable on the basis of their bio-
chemical and immunochemical characteristics
(Rijken & Collen, 1981; Wilson et al., 1980; Rijken
et al., 1981). PAs have important roles in extra-
cellular fibrinolysis to remove fibrin deposit and in
the regulation of various behaviour of normal and
malignant cells including migration, tissue remodel-
ing, and tissue destruction (Strickland & Beers,
1976; Strickland et al., 1976; Vassali et al., 1976).
Recently, a unique human C-type retrovirus,
adult T-cell leukaemia (ATL) virus (ATLV), was
demonstrated in leukaemic cells from patients with
ATL in Japan (Hinuma et al., 1981; Miyoshi et al.,.
1981; Yoshida et al., 1982). At present, it is known
that ATLV is identical to human T-cell leukaemia
virus-I (HTLV-I) originally isolated in a cutaneous
T cell lymphoma cell line in the USA (Propovic et
al., 1982; Watanabe et al., 1984). The virus can be
transmitted to normal adult peripheral and
umbilical cord blood leucocytes accompanied by
transformation by the method of coculture with
HTLV-producing eells (Yamamoto et al., 1982;
Sugamura et al., 1983; Kannagi et al., 1983).
HTLV-bearing cell lines can also be established
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from leucocytes of patients with ATL or HTLV-
carriers using interleukin 2 (IL 2) (Gotoh et al.,
1982; Sugamura et al., 1984a). Cells transformed by
HTLV possess proviral DNA sequences integrated
into the cellular DNA (Yoshida et al., 1982) and
they express HTLV-associated antigens (Yamamoto
et al., 1982; Sugamura et al., 1983; Kannagi et al.,
1983) in most cases and often produce virus-
particles (Miyoshi et al., 1981). Many HTLV- trans-
formed cell lines have been established by these
methods and we reported that some lines could
produce lymphokines including interferon-y (IFN-y)
or phagocytosis inducing factor(s) (Sugamura et al.,
1983; Hinuma et al., 1984). In this study, we
examined the production of PA by HTLV-
transformed T cell lines and found that they
produced PAs constitutively in the culture super-
natants. Furthermore, we found that the PAs
produced by these cell lines were heterogeneous.
Materials and methods
Cell lines
HAMA, KUN, KAN, TCL-Haz, TCL-Ter and
TCL-Mor were the HTLV-transformed cell lines
used. HAMA was established from peripheral blood
leucocytes of a healthy HTLV-carrier; initially it
grew in the presence of IL 2, subsequently without
IL 2. The other HTLV-transformed cell lines were
established from normal peripheral blood leucocytes
after coculture with X-ray-irradiated MT-2 cells as
described previously (Yamamoto et al., 1982;
Sugamura et al., 1983; Kannagi et al., 1983). All
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these lines were positive for HTLV-associated
antigens and T cell surface markers, but negative
for Epstein-Barr virus-associated antigens and
surface immunoglobulins (Yamamoto et al., 1982;
Sugamura et al., 1984a). Other HTLV-negative cell
lines used were as follows. T cell lines; RPMI 8402
(Strivastava et al., 1975), Molt-4 (Strivastava &
Minowada, 1973), and CCRF-CEM (Foley et al.,
1965): B cell lines; Namalwa (Klein et al., 1972),
CESS (Muraguchi et al., 1981), NC 37 (Durr et al.,
1970), and BALL-1 (Miyoshi et al., 1977); myeloma
cell lines; ARH-77 (Burk et al., 1978) and RPMI
8226 (Matsuoka et al., 1967). They were maintained
at 37°C in RPMI 1640 (M.A. Bioproducts,
Maryland, USA) supplemented with 100 gml-1
kanamycin, 2mgml-1 NaHCO3, 25mM N-2-
hydroxyethylpiperazine-N'-2-ethanesulfonic acid
(RPMI 1640 medium), and 10% foetal calf serum
(FCS).
Preparation ofculture supernatants
Cells were washed with RPMI 1640 medium
containing 10% FCS, resuspended at 5 x I0 ml-1
in the same medium and cultured at 37°C for 24-
72h in a volume of 1 ml in Linbro 24-well
microplates (Flow Laboratories, Inc., Milwaukee,
USA) under a humidified atmosphere of 5% CO2 in
air. In some experiments, cells were cultured in the
presence of 40pgml-' concanavalin A (Con A) (P-
L Biochemicals, Inc., Milwaukee, USA), 0.5%
phytohaemagglutinin (PHA) (Difco Laboratories,
Detroit, USA), or 10ngml-1 phorbol miristate
acetate (PMA). After the incubation, the culture
supernatants were obtained by centrifugation at
3,000 rpm for 10min.
Assayfor PA
PA activity in the culture supernatants was
determined by plasminogen-dependent fibrinolysis
using fibrin agar plates. Fibrin agar plates were
prepared as follows: 1.25% special noble agar (Difco
Laboratories, Detroit, USA) dissolved in PBS
(pH 7.4) and prewarmed at 42°C, was quickly mixed
with bovine fibrinogen (Seikagaku Kogyo, Co., Ltd.,
Tokyo, Japan) at a final concentration of
2.0mgml-', bovine plasminogen (0.3 uml-)
(Seikagaku Kogyo, Co., Ltd., Tokyo, Japan), and
bovine thrombin (0.06 uml-1) (Mochida
Pharmaceutical Co., Ltd., Tokyo, Japan). The
mixture (9.6ml) was poured onto a 9 cm plastic
petri dish and incubated at 4°C for 2h. After fibrin
formation, wells (4mm diameter) were punched in
the fibrin agar plate. Ten p1 of a test sample were
added to the wells in duplicate. The plates were
incubated at 37°C for 16h and diameters of lytic
zones were measured by calipers. Plasminogen-
independent fibrinolysis was tested on plasminogen-
free fibrin agar plates. PA activity was expressed in
international units by reference to a urokinase (UK)
(Green Cross, Co., Ltd., Osaka, Japan) standard
curve.
Treatment with anti-UK sera
Five p1 of rabbit anti-UK sera (Green Cross, Co.,
Ltd., Osaka, Japan) diluted 100-fold with PBS and
an equal volume of a test sample were added to the
wells of fibrin agar plates and incubated at 4°C for
1 h; normal rabbit sera served as a control. After
being incubated at 4°C, the plates were incubated at
37°C for a further 16h and the lytic area was
measured. Less than 20 units of UK were
completely neutralized by this treatment.
Polyacrylamide gel electrophoresis ofPAs
Sodium dodecyl sulfate (SDS)-polyacrylamide slab
gels were prepared with upper stacking gels of 4%
acrylamide and lower resolving gels of 10%
acrylamide containing 0.1% SDS. Twenty p1 of a
test sample treated with 0.1% SDS were applied to
the gels and electrophoresed at 4°C for 16h at
4mA/plate. Phosphorylase A (mol.wt92,500), bovine
serum albumin (mol. wt66,200), ovalubumin (mol. wt
45,000), and carbonic anhydrase (mol.wt31,000)
were electrophoresed as standard mol.wt markers
separately from the test samples. After the electro-
phoresis, the gels were washed 4 times in 2.5%
Triton X-100 and subsequently rinsed with distilled
water. The gels were layered on a fibrin agar plate
consisting of 1.25% agar, fibrinogen (2mg),
thrombin (0.06uml -1), andplasminogen(0.3uml -1)
with or without rabbit anti-UK sera (100-fold
dilution). These gels were then incubated at 37°C.
Bands having PA activity were seen under dark-
ground illumination as clear lytic zones in the opaque
fibrin agar plate.
Results
PA activity in the culture supernatants of
HTLV-transformed Tcell lines
PA activity in the culture supernatants of the 6
HTLV-transformed T cell lines and the ten HTLV-
negative cell lines was tested (Table I). PA activity
was detected in the culture supernatants of all the
HTLV-transformed T cell lines. In contrast, no
activity was detected in those of the HTLV-negative
cell lines. Six HTLV-transformed T cell lines
produced considerably different amounts of PA.
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Table I PA activity in the culture supernatants of
various lymphoid cell lines
PA activity (uml -)b
Anti-UK sera
Cell linea treatment Range (No. tested) Average
KUN -
+
TCL-Ter
+
HAMA -
KAN -
TCL-Haz
TCL-Mor
RPMI 8402 -
Molt-4 -
CCRF-CEM -
+
Namalwa
+
CESS -
+
NC 37 -
+
BALL-1 -
+
ARH-77 -
RPMI 8226 -
RPMI 1788 -
3.0-5.6
<0.1
2.3-7.0
<0.1
1.1-4.2
<0.1-0.1
3.8-12.0
0.5-1.5
1.4-6.2
0.6-3.5
0.3-1.1
0.2-0.8
<0.1
<0.1
<0.1
<0.1
<0.1
<0.1
<0.1
<0.1
<0.1
<0.1
<0.1
<0.1
<0.1
<0.1
<0.1
<0.1
<0.1
<0.1
<0.1
<0.1
(3) 4.0
<0.1
(4) 4.4
<0.1
(4) 2.9
0.1
(4) 8.0
1.0
(2) 3.8
2.2
(3) 0.6
0.4
(3) <0.1
<0.1
(3) <0.1
<0.1
(3) <0.1
<0.1
(3) <0.1
<0.1
(3) <0.1
<0.1
(3) <0.1
<0.1
(3) <0.1
<0.1
(3) <0.1
<0.1
(3) <0.1
<0.1
(3) <0.1
<0.1
aCells were cultured at 5 x 10' ml-1 in RPMI 1640
medium containing 10% FCS for 3 days. The culture
supernatants were harvested by centrifugation at
3,000rpm for 10min, and then assayed for PA activity.
bTen/!1 of each culture supernatant was added into the
wells of fibrin agar plates containing plasminogen and
incubated at 37°C for 16h. After the incubation,
fibrinolytic zones were measured and units of PA activity
in their culture supernatants were calculated from a
standard curve of UK.
PA activity, whereas TCL-Mor, produced the
lowest, only 0.6uml- . Plasminogen-independent
fibrinolysis was negligible, if any, in all samples
tested.
Next, we examined whether PA activity from the
HTLV-transformed cell lines was neutralized by
anti-UK sera (Table I). The PA activity from KUN,
TCL-Ter, and HAMA was neutralized almost
completely by the treatment with antisera, whereas
the activity from KAN, TCL-Haz, and TCL-Mor
was only partially neutralized by the same
treatment. These results indicate that KUN, TCL-
Ter, and HAMA produce mainly UK-type PA
whereas the others produce both UK-type and non-
UK-type PAs.
Thus, HTLV-transformed T cell lines con-
stitutively produce PAs in their culture supernatants
and the amounts and molecular species of PA
produced by these cell lines are heterogeneous.
Electrophoresis ofPAs produced by HTLV-
transformed Tcell lines
The culture supernatants of KUN, TCL-Haz, and
KAN were electrophoresed in polyacrylamide gels
containing 0.1% SDS and the bands with
fibrinolytic activity were examined by overlaying
the gels on fibrin agar plates. Fibrinolytic bands
were gradually visualized with time (Figure 1). Two
plasminogen-dependent fibrinolytic bands were
detected in the culture supernatant of KUN. A pair
of closely spaced fibrinolytic bands was observed at
the positions corresponding to mol. wts. of 47,000
and 51,000 estimated by mol.wt standards.
However, no band was detected when the gel was
layered on a fibrin agar plate containing anti-UK
sera. This result indicates that KUN produces two
molecular forms of UK-type PA having different
mol.wts. In the case of TCL-Haz, three fibrinolytic
bands were observed at the positions corresponding
to mol.wts. of - 52,000, 57,000 and 110,000. All
bands were detected on a fibrin agar plate con-
taining anti-UK sera, indicating that these bands
contained non-UK-type PA. As shown in Table I,
- 40% of the total PA activity in the culture
supernatant ofTCL-Haz was neutralized by anti-UK
sera. However, no bands were completely neutralized
by anti-UK sera. Therefore, it seemed that fibrino-
lytic bands of UK-type PA overlapped with those
of non-UK-type. When the culture supernatant of
KAN was electrophoresed, 3 fibrinolytic bands
were detected at the positions of -47,000, 51,000
and 110,000mol.wt. The 47,000mol.wt band was
neutralized by anti-UK sera but the other two
bands of 51,000 and 110,000mol.wts. were not,
indicating that the 47,000mol.wt band contains
UK-type PA and the other two bands contain non-
UK-type. Plasminogen-independent fibrinolysis was
slight in all test samples even after incubation for
12h (data not shown). These results indicate that
HTLV-transformed cell lines produce various
molecular forms of PAs that are distinguishable
not only immunochemically but also by mol.wt.756 S. HINUMA et al.
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Figure 1 Zymogram of PAs produced by HTLV-transformed T cell lines. Culture supernatants of KUN
(lane a), TCL-Haz (lane b), and KAN (lane c) were electrophoresed on SDS-polyacrylamide slab gels and the
resultant gels were overlayed on a fibrin agar plate with (+Anti-UK) or without (-Anti-UK) anti-UK sera.
These fibrin agar plates on which the polyacrylamide gels were overlayed were incubated at 37°C for 7 or 12h
and then photographed under ground illumination. Phosphorylase (mol.wt92,500), bovine serum albumin
(mol. wt66,200), ovalbumin (mol. wt45,000), and carbonic anhydrase (mol. wt31,000) were subjected to
electrophoresis as mol. wt markers; the sizes are indicated as mol. wt x 10-3.
Effect oftreatment with PMA and mitogens on PA
production by HTLV-transformed T cells lines
KUN, TCL-Ter, HAMA, and KAN were cultured
in the presence of PMA, Con A, or PHA and the
effects of these reagents on the production of PA
were examined (Figure 2). PA production by KUN
was decreased by the treatment with PMA and Con
A but was unaffected by PHA. PA production by
TCL-Ter was decreased by Con A and PHA but
increased by PMA. PA production by HAMA was
greatly decreased by PMA and a little diminished
by Con A and PHA. PA production by KAN was
slightly decreased by PMA, ConA, and PHA. Of
the 4 cell lines tested, only KAN produced some
non-UK-type PA, which was not neutralized by
anti-UK sera. It is noticeable that the non-UK-type
PA of KAN was increased by PMA after 24-48h
incubation.
These results indicated that the responses of
HTLV-transformed T cell lines to PMA or
mitogens substantially differed from each other with
respect to PA production. In addition, the
production of UK-type and non-UK-type PA, as
observed on KAN, was affected differently by these
reagents in the same cell line.
Discussion
In this study, we demonstrated that HTLV-trans-
formed T cell lines produce PAs constitutively in
their culture supernatants. In contrast, none of the
HTLV-negative cell lines tested produced detectable
amounts of PA. We have reported that HTLV-
transformed T cell lines produce IFN-y or
phagocytosis inducing factor(s) constitutively in
their culture supernatants (Sugamura et al., 1983;
Hinuma et al., 1984). Recently, Salahuddin et al.
(1984) also reported that human T cell lines trans-
formed by HTLV produced various lymphokines.
These findings indicate that infection with HTLV
induces the production of multiple lymphokines,
including PAs, in lymphocytes. In addition, we
analyzed the molecular characteristics of the PAs
produced by HTLV-transformed T cell lines.
PAs produced by cultured cells of UK-type and
non-UK-type are distinguishable using the
neutralization test with anti-UK sera; many
cultured cells produce UK-type PA, whereas some
cell lines, including those of melanoma and foetal
fibroblast origin, produce the non-UK-type or both
the UK- and non-UK-types (Wilson et al., 1980;
Rijken et al., 1981). PAs produced by these cells
have multiple molecular forms (Wilson et al., 1980;
Rijken et al., 1981). Toullet et al. (1983) reported
that normal B cells stimulated with antigens or
mitogens produced PA in the culture fluid. In
addition, Goldfarb et al. (1984) recently reported
that human large granular lymphocytes (natural
killer cells) produce a PA. Angles-Cano et al. (1984)
reported the heterogeneous expression of PA inPA PRODUCTION BY HTLV-TRANSFORMED T CELLS
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Figure 2 Effect of treatment with PMA, Con A, and PHA on PA production by HTLV-transformed T cell
lines. KUN, TCL-Ter, HAMA, and KAN cells were suspended at 5 x 105mI- in RPMI 1640 medium
containing 10% FCS and cultured with lOngml-1 PMA (0), 40/igml-1 Con A (m), and 0.5% PHA (-) at
37°C under 5% CO2 in air. Cells cultured in the absence of these reagents served as a control (0). After
the cultivation for 24, 48, and 72 h, the culture supernatants were harvested and the PA activity in them was
determined by the fibrin agar plate method. Non-UK-type PA activity was determined after the treatment
with anti-UK sera (+Anti-UK).
moloney virus-transformed murine T cells. How-
ever, the molecular characteristics and physiological
roles of PA produced by lymphocytes are still
unclear. We showed here that HTLV-transformed T
cell lines produced both the UK- and non-UK-type
PAs but that the ratio of the two varied in each cell
line. Moreover, the PA produced by each cell line
was separated into several molecular forms having
different mol. wts on SDS-polyacrylamide gel electro-
phoresis.
It has been reported that PA production by
various cultured cell lines, including retrovirus-
transformed fibroblasts, was enhanced by treatment
with PMA (Goldfarb et al., 1978). In addition, the
production of various lymphokines including PA
from lymphocytes has been reported to be enhanced
by treatment with mitogens (Toullet et al., 1983).
However, the effects of these treatments on the PA
production by HTLV-transformed T cell lines were
substantially different in each line.
The reason for the heterogeneity of PA
production by HTLV-transformed T cell lines is
unclear. It may be due to random activation of
cellular genes by infection with HTLV. Very
recently, Sodroski et al. (1984) demonstrated the
presence of trans-acting transcriptional activating
factors, in HTLV-transformed cells, which might
stimulate the expression of various cellular genes. It
is also possible that differences in the original T cell
subsets of each HTLV-transformed cell line causes
heterogeneity of PA production. Sugamura et al.
(1984b) reported that the target cells for trans-
formation by HTLV were not restricted to a single
cell population. However, Angles-Cano et al. (1984)
reported that no correlation existed between PA
production and cell surface phenotype in retrovirus-
transformed murine T cells. In any case, PA
production by HTLV-transformed cells might be
one of the results of many cellular phenotypic
changes caused by HTLV infection. The physio-
logical significance of PA produced by HTLV-
transformed cells is unknown, though recent reports
indicate that PA productivity and metastatic ability
are closely correlated in some tumour cells (Coen et
al., 1983; Ossoski & Reich, 1983). PA produced by
HTLV-transformed cells may also have important
roles in the regulation of their behaviour.
We are greatly indebted to Drs Y. Sugino and A.
Kakinuma, for their encouragement and helpful
discussions throughout this work.
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